Focosi, Daniele <br/><br/>
Enhancement of hematopoietic stem cell engraftment by inhibition of CXCL12 proteolysis with sitagliptin, an oral dipeptidyl-peptidase IV inhibitor: a report in a case of delayed graft failure.  [electronic resource] 

 -  Leukemia research  Jan 2009 
 - 178-81 p.  digital 
<br/><br/> Publication Type: Case Reports; Letter 
<br/><br/><label>ISSN: </label>0145-2126 
<br/><br/><label>Standard No.: </label>10.1016/j.leukres.2008.04.019  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cell Division<br/>Chemokine CXCL12--antagonists & inhibitors<br/>Dipeptidyl-Peptidase IV Inhibitors<br/>Female<br/>Graft Rejection<br/>Hematopoietic Stem Cells--cytology<br/>Humans<br/>Hydrolysis<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Middle Aged<br/>Protease Inhibitors--pharmacology<br/>Pyrazines--pharmacology<br/>Sitagliptin Phosphate<br/>Triazoles--pharmacology